ArticleBritish journal of cancer2026
INHBA, regulated by C/EBPβ, induces M2 macrophage polarization to promote tumor metastasis and growth via activating the PI3K/AKT pathway in gastric cancer.
Article in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- OLR1 drives gastric cancer progression through NF-κB activation and immunosuppressive macrophage polarization.Medical oncology (Northwood, London, England) · 2026Article
- VCAN promotes the progression and recurrence of esophageal squamous cell carcinoma by remodeling the tumor microenvironment.Scientific reports · 2026Article
- CCAAT/enhancer binding protein β and its role in autoimmune diseases: a promising therapeutic target.Journal of translational medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundGastric cancer (GC) is one of the most common malignant tumors with poor overall survival (OS). The mechanism underlying the progression of GC needs to be investigated in depth.
methodsDifferentially expressed genes (DEGs) were identified based on The Cancer Genome Atlas (TCGA) Stomach Adenocarcinoma (STAD) and Gene Expression Omnibus (GEO) datasets in GC. The function of INHBA in GC was investigated in vitro and in vivo. Dual-luciferase reporter, chromatin immunoprecipitation (ChIP), and western blot assays were performed to identify the target transcription factors. Immune cell infiltration was assessed using CIBERSORT algorithms. M2 macrophage polarization induced by INHBA was detected in vitro. The expression levels of downstream target genes of INHBA were measured at mRNA and protein levels.
resultsINHBA was upregulated in GC cells, and high expression of INHBA was associated with poor OS. INHBA was able to promote GC cell migration, invasion, and tumor metastasis and growth. INHBA expression was upregulated by the transcription factor C/EBPβ. Moreover, INHBA in GC cells mediated M2 macrophage polarization. Of note, our data showed that INHBA activated PI3K/AKT pathway and formed a PI3K/AKT/TGF-β positive feedback loop to promote tumor progression.
conclusionsHigh INHBA expression predicts poor survival of GC patients. INHBA, upregulated by C/EBPβ, induces M2 macrophage polarization to promote tumor metastasis and growth via activating PI3K/AKT pathway in GC. INHBA may be a potential therapeutic target for GC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.